Oshima Tsutomu, Noda Masafumi, Tanaka Keita, Kuno Takashi, Tsukamoto Kiyoshi, Hashimoto Akihiko, Gega Makoto, Yagyuu Toshihiko, Yoshikawa Reigetsu, Ikeuchi Hiroki, Yanagi Hidenori, Yamamura Takehira
Second Dept. of Surgery, Hyogo College of Medicine.
Gan To Kagaku Ryoho. 2007 Apr;34(4):631-4.
The prognosis of a colorectal cancer patient with unresectable hepatic metastases is extremely poor. To improve the prognosis, when the hepatic metastases were initially unresectable, we performed second-look hepatectomy (s-l hepatectomy) after neoadjuvant hepatic arterial 5-FU infusion plus UFT (HAI-PMC). Here, we report the case of a sigmoid colon cancer patient with initially unresectable hepatic metastases showing a prolonged survival (6.5 years) by second-look operation after HAI-PMC. A 57-year-old woman was diagnosed with sigmoid colon cancer with unresectable liver metastases. Sigmoidectomy and hepatic arterial catheterization were performed in the initial operation, and HAI-PMC was performed 6 months after. Metastatic foci of the liver had shrunk (90.9%), but solitary metastatic lung cancer was detected during HAI. As no other metastatic lesion was observed, partial resection of the liver and lung was performed as a second-look operation, 6 months after the initial operation. The woman continued venous infusion chemotherapy as an outpatient, and she survived for 6.5 years after the initial operation. This result suggests that strategic multidisciplinary treatment utilizing s-l hepatectomy after neoadjuvant chemotherapy can lead to better prognosis for colorectal cancer patients with hepatic metastases.
无法切除肝转移的结直肠癌患者预后极差。为改善预后,当肝转移最初无法切除时,我们在新辅助肝动脉5-氟尿嘧啶输注联合优福定(HAI-PMC)后进行了二次探查肝切除术(s-l肝切除术)。在此,我们报告1例乙状结肠癌患者,其最初无法切除的肝转移经HAI-PMC后二次探查手术显示生存期延长(6.5年)。一名57岁女性被诊断为伴有无法切除肝转移的乙状结肠癌。初次手术行乙状结肠切除术及肝动脉插管,6个月后进行HAI-PMC。肝脏转移灶缩小(90.9%),但在HAI期间发现了孤立性转移性肺癌。由于未观察到其他转移病灶,初次手术6个月后作为二次探查手术进行了肝脏和肺的部分切除。该女性作为门诊患者继续接受静脉输注化疗,初次手术后存活了6.5年。这一结果表明,新辅助化疗后采用s-l肝切除术的策略性多学科治疗可使伴有肝转移的结直肠癌患者获得更好的预后。